Optimizing patient access with evidence of product value, effectiveness, and safety from early development through loss of exclusivity.

Learn More
The Evidence Forum

The spring issue of The Evidence Forum is out

Read content related to the relevant issues facing companies along the path to approval and access, including a focus section on digital technologies

Read Now
White Paper

Integrated Scientific Advice during the COVID-19 Pandemic: A Status Update on Key Programs in North America and Europe

Gain insight into the latest updates on sponsors seeking integrated scientific advice during the COVID-19 pandemic

Read Now
Upcoming Webinar

What Do Patients Consider Meaningful Change and How Can Researchers Define It?

Thursday, July 9, 2020 | 10:00AM EDT

Register Now
Upcoming Webinar

COVID-19 Impact on Oncology Treatment Management: HCP Perceptions Versus Reality

Thursday, July 9, 2020 | 8:00AM, 11:00AM, and 5:00PM EDT

Register Now
Latest News

Committed to Supporting Clients During the COVID-19 Pandemic

Access resources and information related to COVID-19 studies to discover how we are joining the COVID-19 fight

Learn More

Our Work In Action

150+ Drugs/Therapies

supported in the past year

30+ Global Extended Access Programs

in the last 3 years alone with thousands of patients transitioning smoothly from investigational to commercial

130+ Payer Submissions

across 20+ countries in the past 5 years, including reversal of multiple NICE decisions

17 of the 20 Top-Selling Drugs

in 2018 supported in the past 5 years

130+ Peer-Reviewed Publications

and 220+ research posters and presentations per year

Learn More

Latest Publications

Any

Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group

  • Value Health
  • July 2020
Immunology

Manufacturing Process Optimization of ADMA Biologics’ Intravenous Immunoglobulin Products, BIVIGAM ® and ASCENIV™

  • Immunotherapy
  • June 2020
Surgery

The Impact of Intra-Abdominal Pressure on Perioperative Outcomes in Laparoscopic Cholecystectomy: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

  • Surgical Endoscopy
  • June 2020
Read More About Our Publications
What We Do

What We Do

Real-World Evidence

Obtain real-world evidence of value by extracting data from existing sources, collecting primary data, and conducting hybrid studies.

Patient-Centered Research

Develop and evaluate clinical outcomes assessments to support labeling and promotional claims.

Evidence Synthesis, Modeling & Communication

Provide a truly connected value story, supported by strong evidence

Market Access

Optimize market access with cogent payer insights, expert-informed evidence strategy, and persuasive communication of product value.

Interventional Studies

Provide peri- and post-approval evidence via dedicated global operations and custom-tailored study designs.

Pragmatic Studies

Explore patient-centered outcomes and comparative effectiveness using pragmatic studies with adaptive designs.

Medical Writing

Expert medical writing, including medical information, study documentation, and publications, tailored to the peri- and post-approval environment.

In Our Own Words

The purchaser of medical devices and diagnostics extends beyond the payer to hospitals, lab facilities, and clinicians. We help our clients develop value propositions that translate clinical value into economic value and construct effective communication tolls appropriate for each stakeholder.

Case Study

Enhancing Oncology Market Access with a Real-World Evidence EAMS Add-on

Discover how Evidera researchers designed an observational study to conceptualize and implement real-world data collection in an Early Access to Medicines Scheme (EAMS) for an oncology therapy.

Read More
Case Study

Evidera Led Effort to Qualify the First Biomarker for COPD Trial Enrichment

Learn how Evidera's partnership with the COPD Foundation Biomarker Qualification Consortium led to the qualification of plasma fibrinogen as the first biomarker in COPD for enrichment of clinical trials by the FDA.

Read More
Careers

Meaningful Work at Every Level

We assess candidates across a variety of scientific and operational functions. From leaders in their fields, to those who are new to the industry. We employ people who have a proactive mind-set when it comes to the work they do and helping the people they work with.

Learn More